Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration–Time Curve: Based on Peak and Trough Concentrations in Saliva

Author:

Xu Baohua12,Zhou Jianxing12,Zheng You12ORCID,Xu Ruichao3,Liu Qingxia12,Li Dandan1,Liu Maobai2,Wu Xuemei2ORCID

Affiliation:

1. School of Pharmacy Fujian Medical University Fuzhou Fujian China

2. Department of Pharmacy Fujian Medical University Union Hospital Fuzhou Fujian China

3. Quantitative Clinical Pharmacology Takeda Development Center Americas, Inc Lexington MA USA

Abstract

AbstractTherapeutic drug monitoring for busulfan is currently performed by multiple plasma sampling. Saliva is considered a noninvasive therapeutic drug monitoring matrix. This study aimed to investigate intravenous busulfan pharmacokinetics (PK) in plasma and saliva, and establish a limited sampling strategy (LSS) for predicting the area under the concentration–time curve from time zero to infinity in plasma (AUC0‐∞,p) by using saliva samples. Therefore, the PK of busulfan was studied in 37 Chinese patients. Pearson correlation analysis was used to evaluate the correlation between the AUC of busulfan in plasma and saliva. LSS models were established by the multiple linear regression analysis. The prediction error, the mean prediction error, and the root mean square error were used to evaluate the predictive accuracy. The agreement between the predicted and observed AUC0‐∞ in saliva was investigated by the intraclass correlation coefficient and Bland–Altman analysis. The accuracy and robustness of the models were evaluated by using the bootstrap procedure. The result of PK analysis 62.2% of patients (23/37) was within the target range of AUC0‐∞,p. A good correlation between saliva and plasma busulfan AUC0‐∞ was observed (r = 0.63, p < .01). The bias and precision of the models 7 and 13 were less than 15%. The intraclass correlation coefficient exceeded 0.9, and the limits of agreement were within ±15%. The 2‐point LSS model in saliva is a convenient and desirable approach to predict the AUC0‐∞ of 4 times daily intravenous busulfan in plasma, which can be used to design personalized dosing for busulfan.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3